Literature DB >> 11111012

The psychosocial impact of psoriasis: physical severity, quality of life, and stigmatization.

S B Perrott1, A H Murray, J Lowe, C M Mathieson.   

Abstract

Men (N=58) and women (N=43) living with psoriasis completed questionnaires assessing quality of life and feelings of stigmatization. Physician ratings of disease severity were used in conjunction with these variables to account for psychosocial impact. Results showed that ratings of severity were poor predictors of quality of life and stigmatization. Demographic variables (e.g., sex and education) were also generally poor predictors of psychosocial outcome. It is concluded that attempts to understand the psychological impact of psoriasis in terms of current measures of disease severity and demographic characteristics will be limited.

Entities:  

Mesh：

Year:  2000        PMID： 11111012     DOI： 10.1016/s0031-9384(00)00290-0

Source DB:  PubMed          Journal:  Physiol Behav        ISSN： 0031-9384


  15 in total

1.  How psoriasis patients perceive, obtain, and use biologic agents: Survey from an academic medical center.

Authors:  Faranak Kamangar; Leah Isip; Tina Bhutani; Madison Dennis; Misha M Heller; Eric S Lee; Hong Nie; Wilson Liao
Journal:  J Dermatolog Treat       Date:  2011-11-10       Impact factor: 3.359

2.  Patient-reported outcomes for psoriasis patients with clear versus almost clear skin in the clinical setting.

Authors:  Junko Takeshita; Kristina Callis Duffin; Daniel B Shin; Gerald G Krueger; Andrew D Robertson; Andrea B Troxel; Abby S Van Voorhees; Joel M Gelfand
Journal:  J Am Acad Dermatol       Date:  2014-06-11       Impact factor: 11.527

3.  Stigma and related influencing factors in postoperative oral cancer patients in China: a cross-sectional study.

Authors:  Chuxia Tan; Chenxi Zhong; Ranran Mei; Ronghong Yang; Dangdang Wang; Xianjiao Deng; Shihao Chen; Man Ye
Journal:  Support Care Cancer       Date:  2022-03-19       Impact factor: 3.603

Review 4.  Evaluating Risk Tolerance from a Systematic Review of Preferences: The Case of Patients with Psoriasis.

Authors:  Juan Marcos Gonzalez
Journal:  Patient       Date:  2018-06       Impact factor: 3.883

5.  [German version of the Skin Shame Scale (SSS-24) : Validation with dermatological patients and dermatologically healthy individuals].

Authors:  Michaela Hiebler-Ragger; Human-Friedrich Unterrainer; Andrew R Thompson; Stephen Kellett; Elisabeth Aberer
Journal:  Hautarzt       Date:  2020-02       Impact factor: 0.751

6.  [Stigmatization and quality of life of patients with psoriasis and atopic dermatitis].

Authors:  G Schmid-Ott; R Burchard; H H Niederauer; F Lamprecht; H-W Künsebeck
Journal:  Hautarzt       Date:  2003-07-01       Impact factor: 0.751

7.  Relationship Between Skin Shame, Psychological Distress and Quality of Life in Patients with Psoriasis: a Pilot Study.

Authors:  Donja Homayoon; Michaela Hiebler-Ragger; Moritz Zenker; Wolfgang Weger; Human Unterrainer; Elisabeth Aberer
Journal:  Acta Derm Venereol       Date:  2020-07-02       Impact factor: 3.875

Review 8.  Management of the psychological comorbidities of dermatological conditions: practitioners' guidelines.

Authors:  Cody J Connor
Journal:  Clin Cosmet Investig Dermatol       Date:  2017-04-20

9.  Development and psychometric validation of the REFlective evaLuation of psoriasis Efficacy of Treatment and Severity (REFLETS) questionnaire: a common measure of plaque-type psoriasis severity and treatment efficacy for patients and clinicians.

Authors:  H Gilet; A Roborel de Climens; B Arnould; H Bachelez; M Bagot; P Beaulieu; P Joly; D Jullien; M Le Maître; J P Ortonne; C Paul; E Thibout
Journal:  J Eur Acad Dermatol Venereol       Date:  2014-07-25       Impact factor: 6.166

10.  Suicide risk and psychiatric comorbidity in patients with psoriasis.

Authors:  Maurizio Pompili; Marco Innamorati; Sara Trovarelli; Alessandra Narcisi; Samantha Bellini; Diego Orsini; Alberto Forte; Denise Erbuto; Elisabetta Botti; Dorian A Lamis; Paolo Girardi; Antonio Costanzo
Journal:  J Int Med Res       Date:  2016-09       Impact factor: 1.671
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.